How single-use technologies can improve antibodies production
Drug Discovery World
MAY 7, 2024
Where the bottlenecks of achieving higher cell density and higher titers were once thought to be issues of the past, hurdles have now shifted to achieving speed and scale in mAb production without sacrificing quality. DC: Antibodies have and remain a large product class within the biopharmaceutical market.
Let's personalize your content